Treatment Study of Vacuum Assisted Closure for Postsurgical Subcutaneous Abdominal Wound Healing Impairments
SAWHI
Treatment of Subcutaneous Abdominal Wound Healing Impairment After Surgery Without Fascial Dehiscence by Vacuum Assisted Closure™(SAWHI-V.A.C.® Study) Versus Standard Conventional Wound Therapy
2 other identifiers
interventional
539
2 countries
15
Brief Summary
This clinical study is performed in several German, Dutch and Belgian hospitals to evaluate the efficacy of Vacuum Assisted Closure® (V.A.C.®) for the treatment of postsurgical abdominal wound healing impairments after surgery. Therefore the underlying layer of fibrous tissue that permeates the internal organs must be intact. Main outcome measure is the time until complete wound closure that sustained for a minimum of 14 days. Furthermore the therapy options will be examined regarding several other clinical, safety, patient reported and economic parameters. Patients will be assigned equally and by chance to both treatment groups. Study participants as well as the attending doctors and nurses will be informed about the assignment to the respective treatment arm. The primary outcome measure and some of the secondary parameters like reappearance of the wound and the development of the wound size over time, examined within an active study treatment time of 42 days, will be photographed and analysed under the use of a central computer system. The central analysing personal will not be informed about patient details or therapy allocation. Patients with at first closed belly wounds with wound healing disorder in the postoperative course after surgery without an opening of the underlying layer of fibrous tissue are eligible to be included in the trial if the diagnosis of a wound healing impairment in the postoperative course is manifested as a wound with spontaneous dehiscence, a wound that requires an active reopening of the suture by the treating physician or a wound that cannot be closed by primary intention and requires further treatment to achieve permanent closure. Study participants will be selected and enrolled within clinical surgical departments which provide the respective personal, structural and scientific background for the conduction of the trial project. Trial therapy will be started in-hospital and may be continued in ambulatory care. It is very important to examine the therapy options also in the ambulant care setting thus study participants with good health who are able to continue the specific wound treatment in ambulant should be transferred to the ambulant service as soon as possible.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2011
Longer than P75 for not_applicable
15 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 2, 2011
CompletedFirst Submitted
Initial submission to the registry
February 2, 2012
CompletedFirst Posted
Study publicly available on registry
February 7, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 14, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 11, 2018
CompletedResults Posted
Study results publicly available
June 25, 2020
CompletedJune 25, 2020
June 1, 2020
6.6 years
February 2, 2012
April 30, 2020
June 24, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Time to Complete Wound Closure
Time (number of days) to achieve complete wound closure verified by photo documentation and blinded, computer-based wound quality assessment as well as wound closure confirmation after 14 consecutive days (14 days -0 / + 3) Complete wound closure is defined as: 100% epithelialization No drainage from the wound No need for adjuvant therapy or dressing No presence of sutures
42 days
Secondary Outcomes (2)
Incidence of Confirmed and Verified Wound Closure
42 days
Recurrence
132 days
Study Arms (2)
Vacuum Assisted Closure®
EXPERIMENTALNegative pressure wound therapy
Standard conventional wound therapy
ACTIVE COMPARATORAccording to institutional clinical standards
Interventions
Vacuum Assisted Closure® (V.A.C.®) Therapy within a maximum study treatment time of 42 days. VAC® Therapy Systems used within the trial are ActiV.A.C.®, InfoV.A.C.®, V.A.C. Freedom®, V.A.C. Via® and VAC Ulta®. All used systems are equally eligible for the treatment of subcutaneous abdominal wounds and should be used according to availability and local preferences within the trial site. Systems differ regarding user surface and display and processing of data. For the treatment of subcutaneous abdominal wounds the V.A.C.® Granufoam Dressing (size medium and big) is recommended.
Standard conventional wound therapy (SCWT) according to institutional clinical standards within a maximum study treatment time of 42 days
Eligibility Criteria
You may qualify if:
- Written informed consent
- Post-surgical subcutaneous abdominal wound healing impairment
You may not qualify if:
- Age \< 18
- Noncompliance with study procedures, visit schedule and follow up
- Pregnancy
- Present or nonclosable defect of the abdominal fascia
- Any pre-existing or ongoing organ system failure, that cannot be stabilized or solved by appropriate medical treatment
- Necrotic tissue with eschar present
- Non-enteric and unexplored fistulas
- Malignancy of the wound
- Use of any other device based on the principle of negative pressure wound therapy on the study wound within ≤ 8 days prior to screening
- Competing therapies or procedures
- Simultaneous participation in other clinical trials
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Witten/Herdeckelead
- KCI Europe Holding B.V.collaborator
Study Sites (15)
UZ Brussel
Brussels, 1090, Belgium
Department of Abdominal Surgery Gasthuisberg University Hospital
Leuven, 3000, Belgium
Sana Klinikum Lichtenberg (Berlin)
Berlin, 10365, Germany
Unfallkrankenhaus Berlin Klinik für Allgemein- und Viszeralchirurgie
Berlin, 12683, Germany
St. Josef-Hospital gGmbH Universitätsklinikum der Ruhr-Universität Bochum
Bochum, 44791, Germany
Universitätsmedizin Göttingen
Göttingen, 37075, Germany
Universitätsklinikum des Saarlandes, Klinik für Allgemeine Chirurgie, Viszeral-, Gefäß- und Kinderchirurgie
Homburg, 66421, Germany
UNIVERSITÄTSMEDIZIN der Johannes Gutenberg-Universität
Mainz, 55131, Germany
Universitätsmedizin Mannheim Medizinische Fakultät Mannheim der Universität Heidelberg Chirurgische Klinik
Mannheim, 68167, Germany
Chirurgische Klinik und Poliklinik, Klinikum rechts der Isar
München, 81675, Germany
Ruppiner Kliniken GmbH
Neuruppin, 16816, Germany
Klinikum Ernst von Bergmann, Klinik für Allgemein- und Visceralchirurgie
Potsdam, 14467, Germany
Diakoniekrankenhaus Rotenburg
Rotenburg (Wümme), 27356, Germany
Thüringen-Kliniken "Georgius Agricola" GmbH
Saalfeld, 07318, Germany
GRN-Klinik Sinsheim, Allgemein- und Viszeralchirurgie
Sinsheim, 74889, Germany
Related Publications (3)
Seidel D, Lefering R, Neugebauer EA. Treatment of subcutaneous abdominal wound healing impairment after surgery without fascial dehiscence by vacuum assisted closure (SAWHI-V.A.C.(R)-study) versus standard conventional wound therapy: study protocol for a randomized controlled trial. Trials. 2013 Nov 20;14:394. doi: 10.1186/1745-6215-14-394.
PMID: 24252551BACKGROUNDSeidel D, Diedrich S, Herrle F, Thielemann H, Marusch F, Schirren R, Talaulicar R, Gehrig T, Lehwald-Tywuschik N, Glanemann M, Bunse J, Huttemann M, Braumann C, Heizmann O, Miserez M, Kronert T, Gretschel S, Lefering R. Negative Pressure Wound Therapy vs Conventional Wound Treatment in Subcutaneous Abdominal Wound Healing Impairment: The SAWHI Randomized Clinical Trial. JAMA Surg. 2020 Jun 1;155(6):469-478. doi: 10.1001/jamasurg.2020.0414.
PMID: 32293657RESULTSeidel D; SAWHI study group. Ambulatory negative pressure wound therapy of subcutaneous abdominal wounds after surgery: results of the SAWHI randomized clinical trial. BMC Surg. 2022 Dec 12;22(1):425. doi: 10.1186/s12893-022-01863-x.
PMID: 36503505DERIVED
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dörthe Seidel
- Organization
- Witten/Herdecke University
Study Officials
- PRINCIPAL INVESTIGATOR
Doerthe Seidel
Witten / Herdecke University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Interim Scientific Leader of the Centre for Clinical Trials and Innovation
Study Record Dates
First Submitted
February 2, 2012
First Posted
February 7, 2012
Study Start
August 2, 2011
Primary Completion
March 14, 2018
Study Completion
June 11, 2018
Last Updated
June 25, 2020
Results First Posted
June 25, 2020
Record last verified: 2020-06